Evidence map›Paper›PMID 39394103›Full record

ArticleBMC public health2024

Implementation lessons learned from the University of California's Diabetes Prevention Program Initiative.

Tamra Burns Loeb, Kate Ramm, Maryam Gholami, Kelly Shedd, Samantha Soetenga, Meera Bhagat, Nicholas J Jackson, Un Young Rebecca Chung, O Kenrik Duru, Carol M Mangione and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Tamra Burns LoebDavid Geffen School of Medicine at the University of California, Los Angeles, CA, USA. Tloeb@mednet.ucla.edu.
Kate RammDavid Geffen School of Medicine at the University of California, Los Angeles, CA, USA.
Maryam GholamiAltman Clinical and Translational Research Institute (ACTRI), University of California, San Diego, USA.
Kelly SheddUniversity of California, Irvine, USA.
Samantha SoetengaCampus Recreation, University of California, Los Angeles, CA, USA.
Meera BhagatDavid Geffen School of Medicine at the University of California, Los Angeles, CA, USA.
Nicholas J JacksonDavid Geffen School of Medicine at the University of California, Los Angeles, CA, USA.
Un Young Rebecca ChungDavid Geffen School of Medicine at the University of California, Los Angeles, CA, USA.
O Kenrik DuruDavid Geffen School of Medicine at the University of California, Los Angeles, CA, USA.
Carol M MangioneDavid Geffen School of Medicine at the University of California, Los Angeles, CA, USA.
Alison B HamiltonDavid Geffen School of Medicine at the University of California, Los Angeles, CA, USA.
Tannaz MoinDavid Geffen School of Medicine at the University of California, Los Angeles, CA, USA.

Funding

The UC DPP Study: Evaluating a Diabetes Prevention Initiative Across the University of California SystemR01DK124503 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MOIN, TANNAZ · 2020 to 2023
$2.0M
NIDDK NIH HHS R01 DK124503
6 · The paper itself

Abstract

backgroundThe University of California's Diabetes Prevention Program (UC DPP) Initiative was implemented systemwide to address diabetes and obesity risk on all 10 campuses. As little is known about implementing lifestyle change programs in university settings, we examined implementation partners' (i.e., UC DPP leaders and campus leads) perceptions of factors influencing program success on UC campuses.

methodsWe conducted qualitative interviews with UC DPP leaders and campus leads to examine challenges and opportunities with university-based DPP delivery models. Interviews were recorded, professionally transcribed, and reviewed in detail by the research team. Transcripts were analyzed using rapid qualitative analysis (RQA). The study was approved by the UCLA Institutional Review Board. All implementation partners provided verbal informed consent.

resultsTwenty-six implementation partners (8 UC DPP leaders and 18 campus leads) completed interviews in 2021. Seven themes were identified as critical for implementation, including (1) marketing and recruitment (i.e., market and recruit broadly through established channels as well as target at-risk populations); (2) enrollment (i.e., offer the program during convenient times and let participants know what to expect); (3) use an adaptable, evidence-based program; (4) secure funding for the program, participants, lifestyle coaches, and space; (5) hire experienced and dedicated staff and lifestyle coaches; (6) ensure leadership support; and (7) utilize campus linkages and resources. Perceptions of challenges faced with respect to these themes are also described.

conclusionsThis is one of the first studies to examine the challenges and opportunities of delivering an intensive lifestyle change program across 10 university sites. Understanding factors that enhance success of university-based diabetes prevention programs can facilitate UC DPP efforts and help inform delivery strategies of health and wellness programs across other university settings more broadly.

Indexed as

Qualitative ResearchCaliforniaDiabetes Mellitus, Type 2Health PromotionHumansInterviews as TopicObesityProgram DevelopmentProgram EvaluationUniversitiesDiabetes prevention programFactors influencing successImplementation partnersUniversity-based

Identifiers

PMID39394103
PMCPMC11468268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.